Literature DB >> 31206586

Constructing a confidence interval for the fraction who benefit from treatment, using randomized trial data.

Emily J Huang1, Ethan X Fang2, Daniel F Hanley3, Michael Rosenblum4.   

Abstract

The fraction who benefit from treatment is the proportion of patients whose potential outcome under treatment is better than that under control. Inference on this parameter is challenging since it is only partially identifiable, even in our context of a randomized trial. We propose a new method for constructing a confidence interval for the fraction, when the outcome is ordinal or binary. Our confidence interval procedure is pointwise consistent. It does not require any assumptions about the joint distribution of the potential outcomes, although it has the flexibility to incorporate various user-defined assumptions. Our method is based on a stochastic optimization technique involving a second-order, asymptotic approximation that, to the best of our knowledge, has not been applied to biomedical studies. This approximation leads to statistics that are solutions to quadratic programs, which can be computed efficiently using optimization tools. In simulation, our method attains the nominal coverage probability or higher, and can have narrower average width than competitor methods. We apply it to a trial of a new intervention for stroke.
© 2019 The International Biometric Society.

Entities:  

Keywords:  causal inference; potential outcome; quadratic program; treatment effect heterogeneity

Mesh:

Year:  2019        PMID: 31206586      PMCID: PMC6895397          DOI: 10.1111/biom.13101

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  8 in total

1.  Ordinal probability effect measures for group comparisons in multinomial cumulative link models.

Authors:  Alan Agresti; Maria Kateri
Journal:  Biometrics       Date:  2016-07-20       Impact factor: 2.571

2.  Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.

Authors:  Daniel F Hanley; Karen Lane; Nichol McBee; Wendy Ziai; Stanley Tuhrim; Kennedy R Lees; Jesse Dawson; Dheeraj Gandhi; Natalie Ullman; W Andrew Mould; Steven W Mayo; A David Mendelow; Barbara Gregson; Kenneth Butcher; Paul Vespa; David W Wright; Carlos S Kase; J Ricardo Carhuapoma; Penelope M Keyl; Marie Diener-West; John Muschelli; Joshua F Betz; Carol B Thompson; Elizabeth A Sugar; Gayane Yenokyan; Scott Janis; Sayona John; Sagi Harnof; George A Lopez; E Francois Aldrich; Mark R Harrigan; Safdar Ansari; Jack Jallo; Jean-Louis Caron; David LeDoux; Opeolu Adeoye; Mario Zuccarello; Harold P Adams; Michael Rosenblum; Richard E Thompson; Issam A Awad
Journal:  Lancet       Date:  2017-01-10       Impact factor: 79.321

3.  Inequality in treatment benefits: Can we determine if a new treatment benefits the many or the few?

Authors:  Emily J Huang; Ethan X Fang; Daniel F Hanley; Michael Rosenblum
Journal:  Biostatistics       Date:  2017-04-01       Impact factor: 5.899

4.  Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.

Authors:  Yasutaka Chiba
Journal:  Stat Med       Date:  2017-07-13       Impact factor: 2.373

5.  Assessing the heterogeneity of treatment effects via potential outcomes of individual patients.

Authors:  Zhiwei Zhang; Chenguang Wang; Lei Nie; Guoxing Soon
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-11       Impact factor: 1.864

6.  Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experiments.

Authors:  Michael P Fay; Erica H Brittain; Joanna H Shih; Dean A Follmann; Erin E Gabriel
Journal:  Stat Med       Date:  2018-05-17       Impact factor: 2.373

7.  Influence of stroke infarct location on functional outcome measured by the modified rankin scale.

Authors:  Bastian Cheng; Nils Daniel Forkert; Melissa Zavaglia; Claus C Hilgetag; Amir Golsari; Susanne Siemonsen; Jens Fiehler; Salvador Pedraza; Josep Puig; Tae-Hee Cho; Josef Alawneh; Jean-Claude Baron; Leif Ostergaard; Christian Gerloff; Götz Thomalla
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

8.  Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.

Authors:  Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.